Autologous Exosomes in Hair Restoration: The Science Behind MyExo
Hair restoration is one of the key fields of application for autologous exosome-rich plasma. In androgenetic alopecia, exosomes enhance dermal papilla cell activity, extend the anagen phase and improve scalp vascularity. Repeated sessions support visible improvements in hair density and thickness.
MyExo delivers 12 trillion exosomes in a 10 mL final volume, with an average exosome size of 120 nm (±15).
The biology behind the effect
- Cellular communication: exosomes deliver regulatory RNAs and proteins that activate PI3K/AKT, ERK/MAPK and STAT3 pathways, supporting cell survival, proliferation and differentiation
- Angiogenesis: signals that promote neovascularisation in endothelial cells support scalp vascularity
- Growth-factor cooperation: platelet-derived PDGF, VEGF, TGF-β and IGF-1 act synergistically with exosomes, attracting cells and improving vascular supply
Why the source matters
MyExo is 100% autologous: the exosomes are harvested from the patient’s own PRP, with no donor material, animal or plant source, and no additives. The fraction is prepared fresh in a closed system in about 30 minutes, under physician control.
Where MyExo fits with PRP
PRP has the strongest current clinical background in hair. MyExo builds on the same autologous starting point and adds a mechanically stimulated, exosome-rich signalling fraction. The manufacturer describes product-specific public clinical evidence as still more limited than for PRP, so MyExo is best presented as a next-generation autologous platform rather than a replacement for PRP.
Learn more about the kit, its components and laboratory characterisation on the MyExo product page, or contact our team on WhatsApp +971 52 124 4440.
For healthcare professionals. Product information is provided by the manufacturer (t-lab) and is general in nature; it is not medical advice. Treatment decisions should be made by a qualified physician. MyExo by Elixir is distributed by Bionics Medical in the UAE and Saudi Arabia.